Adicet Bio Inc
ACET
$2.78+1.09%
At close · Nov 17, 2026
Mkt cap
$75.72M
EV/Sales
—
P/E ratio
—
FY2025 Revenue
$5.78M
EPS (TTM)
−$21.63
Gross Margin (FY2025)
—
Profit Margin (FY2025)
−2021.86%
Beta
—
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
ACET earnings
Analysts
Sector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Nov 13, 2026
Latest stored headlines
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Latest reported ACET revenue for 2025-12-31 was $5.8M. Net income was -$116.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ACET currently screens at market cap $75.7M.
Use this ACET research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ACET income, balance, and cash tables.
Adicet Bio Inc (ACET) is a biotechnology company in the Healthcare sector.
Latest cached Adicet Bio Inc (ACET) revenue for Dec 31, 2025 was $5.8M. Net income was -$116.8M. Statements: https://lician.com/financials/acet
Adicet Bio Inc (ACET) market capitalization is $75.7M on the latest cached snapshot.
Adicet Bio Inc (ACET) cached previous close $2.75; day range $2.60 – $2.84; volume 389,560. Session quote: https://lician.com/quote/acet
Adicet Bio Inc (ACET) latest cached earnings event is "ACET earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ACET filing is 8-K · Nov 13, 2026. Filings: https://lician.com/sec/acet
SEC filings · latest fiscal year FY2025
Free shows the newest 2 years. FY2022–FY2023 on Pro
−46.1%
Revenue growth year over year
10-Q results and the earnings calendar
Revenue and EPS are GAAP diluted from the 10-Q. Beat or miss compares the calendar's actual with its estimate on the same basis (adj.), or revenue with the revenue estimate.
Institutional holders from SEC 13F filings
Quant rating
MetricsHow it works—Not rated: market cap below $100M. Factor grades are still shown.
Lician Quant Grades · vs 576 Healthcare stocks · Nov 17, 2026
Next earnings
Thu, Mar 4Lician estimate
Time not announced · in 107 days
EPS est. —
Lician projectionEarnings
Short interest
459.6Kshares short
2.6 days to cover
−11.9% vs prior report
FINRA · settled Oct 30Short data
52-week range
$2.75$10.37
Price $2.78 · 73.2% below high
Low $2.75, high $10.37, last $2.78.Daily closesChart
Get alerted when ACET confirms or moves its Mar 4 report
Free account, no card. Earnings date alerts are free for every stock on your watchlist; beat/miss results come with Pro.